EUVIMEDScopri EUVIMED
Crossref

Dyslipidemia: End Stage Renal Disease and Hemodialysis

The Internet Journal of Nephrology · 2009 · 5 (1)

DOI: 10.5580/169c ↗

At a glance

Journal article in The Internet Journal of Nephrology, 2009. Cited 1 times so far (Crossref).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Chronic renal failure (CRF) is a pro-oxidant state and the degree of intracellular and extracellular oxidative stress is related to the severity of renal failure. The present study was taken up to evaluate Dyslipidemia in patients undergoing hemodialysis session. In our study, the hemodialysis patients were found to have Dyslipidemia as evidenced by HD can moderately attenuate the renal dyslipidemia. Accumulation of atherogenic lipoproteins could also play a role in the development of atherosclerotic complications in HD patients. This Dyslipidemia plays an important role in the development of atherosclerosis in hemodialysis

Cite

APA

(2009). Dyslipidemia: End Stage Renal Disease and Hemodialysis. The Internet Journal of Nephrology. https://doi.org/10.5580/169c

Vancouver

Dyslipidemia: End Stage Renal Disease and Hemodialysis. The Internet Journal of Nephrology. 2009. doi:10.5580/169c

BibTeX
@article{euvimed2009,
  title = {Dyslipidemia: End Stage Renal Disease and Hemodialysis},
  journal = {The Internet Journal of Nephrology},
  year = {2009},
  doi = {10.5580/169c}
}
Start for free →